Safety and Efficacy of Monoclonal Anti-Tau Antibody in the Treatment of Alzheimer’s Disease (P12-3.002)
We aimed to assess the safety and efficacy of anti-tau monoclonal antibodies in treating Alzheimer’s Disease (AD).
Authors
- Gabriel Monteiro (ORCID: https://orcid.org/0000-0003-0572-1731)
- Antônio Mutarelli (ORCID: https://orcid.org/0000-0002-5595-9433)
- João Paulo Telles (ORCID: https://orcid.org/0000-0003-4078-2046)
- Julyana Medeiros Dantas (ORCID: https://orcid.org/0000-0002-0915-0932)
- Felipe Baptista Brunheroto (ORCID: https://orcid.org/0000-0002-1986-4453)
- Gabriel Marinheiro (ORCID: https://orcid.org/0009-0001-8040-6515)
Institutions
- United Food and Commercial Workers (US)
- Universidad San Pedro (PE)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212096
- Primary Topic
- Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00